GlaxoSmithKline reported 1.35B in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alcon AG ALC:SW 20M 0
Amgen AMGN:US $ 31989M 112M
AstraZeneca AZN:LN 387M 59M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Fresenius FRE:GR € 558M 0M
Galapagos GLPG:NA € 291.95M 0.04M
Genmab GEN:DC DK 66M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
GRIFOLS GRF:SM € 119.6M 0M
H. Lundbeck A/S LUN:DC 996M 0
Hikma Pharmaceutical HIK:LN 41M 0
Lonza Group LONN:SW 74M 0
Merck MRK:GR € 168M 0M
Novartis NOVN:VX SF 901M 12M
Orion ORNBV:FH € 92.2M 0M
Recordati REC:IM € 26.14M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M